Zacks Investment Research on MSN

Biogen wins FDA approval for subcutaneous starter dose of Leqembi

Shares of Biogen BIIB rose nearly 5% yesterday after the company announced that the FDA approved a subcutaneous (SC) ...
Cancer Therapy Advisor

Subcutaneous Sarclisa Escena Receives FDA Nod for Multiple Myeloma

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Sanofi wins FDA nod for injectable multiple myeloma therapy

Sanofi (SNY) wins FDA approval for Sarclisa Escena, a subcutaneously-delivered version of its multiple myeloma therapy ...
oncnursingnews

FDA Approves Subcutaneous Isatuximab-irfc for Multiple Myeloma

FDA approves subcutaneous isatuximab-irfc for multiple myeloma indications, offering an efficient delivery alternative to intravenous administration. The US Food and Drug Administration (FDA) has ...